Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 3. Anticancer activity of ITCs on HepG2 cells after treatment for 24 h: structure (A), IC50 (B), cell viability profile (C), and mode of cell death (D). Cell viability presented as percentage relative to untreated control. In mode of cell death study, HepG2 cells treated with 80 μM ITCs. Living, apoptotic, and necrotic represented as percentage to total cell population in each treatment group. All data presented as mean ± SD (n=3).
Biomolecules & Therapeutics 2019;27:540~552
© Biomolecules & Therapeutics